Cargando…
Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study
BACKGROUND: It has been observed that COVID-19 may cause myocardial damage, but there are few detailed reports on myocardial enzyme abnormalities. METHODS: In this retrospective study, we analyzed data from 157 consecutive laboratory-confirmed and hospitalized COVID-19 patients from Wuhan. We collec...
Autores principales: | Zhang, Qilin, Zheng, Ziming, Zhang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556588/ https://www.ncbi.nlm.nih.gov/pubmed/34725560 http://dx.doi.org/10.1155/2021/3440714 |
Ejemplares similares
-
Abnormal myocardial enzymes in the prediction of mortality and hypertension in COVID-19 patients: a retrospective study
por: Sha, Shuang, et al.
Publicado: (2022) -
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients
por: Cheng, Jingping, et al.
Publicado: (2021) -
Impact of baseline abnormal liver enzymes in the outcome of COVID-19 infection
por: Farias, João Pedro, et al.
Publicado: (2023) -
Association of electrocardiographic abnormalities and COVID-19 clinical outcomes
por: Jabbari, Latifeh, et al.
Publicado: (2023) -
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome
por: Carubbi, Francesco, et al.
Publicado: (2022)